Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review

Lung Cancer

Volumn 68, Issue 2, 2010, Pages 137-145

  Chen, Sisi ^a   Flower, Andrew ^e   Ritchie, Andrew ^b   Liu, Jianping ^c   Molassiotis, Alex ^d   Yu, He ^e   Lewith, George ^e  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b Basildon Thurrock University Hospitals Foundation NHS Trust   (United Kingdom)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e Aldermoor Health Centre   (United Kingdom)

Author keywords

Chinese herbal medicine; Complementary medicine; Non small cell lung cancer; Systematic review

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; HERBACEOUS AGENT; MEDROXYPROGESTERONE ACETATE; MELPHALAN; MITOMYCIN; NAVELBINE; PACLITAXEL; VINCRISTINE; VINDESINE;

ADJUVANT THERAPY; ANEMIA; ANGELICA SINENSIS; ANXIETY; ASTRAGALUS MEMBRANACEUS; CANCER CHEMOTHERAPY; CANCER STAGING; CHEMOTHERAPY INDUCED EMESIS; CHINESE MEDICINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CURCUMA ZEDOARIA; DECREASED APPETITE; DIARRHEA; DRUG EFFICACY; ECG ABNORMALITY; HERB; HUMAN; KARNOFSKY PERFORMANCE STATUS; KIDNEY DYSFUNCTION; LEUKOCYTE COUNT; LIVER FUNCTION TEST; LUNG NON SMALL CELL CANCER; NAUSEA; NEUTROPENIA; OLDENLANDIA DIFFUSA; OPHIOPOGON JAPONICUS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; XEROSTOMIA;

ADMINISTRATION, ORAL; ANEMIA; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; DRUG THERAPY; DRUGS, CHINESE HERBAL; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; NEUTROPENIA; QUALITY OF LIFE;

EID: 77950459454     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.11.008     Document Type: Review

References (45)

1. Office for National Statistics. Cancer Statistics Registrations: registrations of cancer diagnosed in 2004, England. Series MB1 No. 33. London: National Statistics; 2005.
2. Office for National Statistics. Mortality statistics; 2007.
3. National Institute for Clinical Excellence. Lung cancer. The diagnosis and treatment of lung cancer; 2005.
4. Hoffman P.C., Mauer A.M., Vokes E.E. Lung cancer. Lancet 2000, 355:479-485.
5. Carney D.N., Hansen H.H. Non-small-cell lung cancer-stalemate or progress?. New England Journal of Medicine 2000, 343(17):1261-1262.
6. National Audit Office. Tackling cancer in England: saving more lives. Report by the controller and auditor general. London: Stationery Office; 2004.
7. Office for National Statistics 2001. Mortality statistics cause. Review of the Registrar General on deaths by cause, sex and age in England and Wales. London: Office for National Statistics; 2000: p. 27.
8. Office for National Statistics 2001. Cancer survival, England 1993-2000. London: Office for National Statistics.
9. Manser RL, Irving LB, Stone C, et al. Screening for lung cancer. In: The Cochrane Library, issue 1; 2004.
10. Ezzo J, Richardson MA, Vickers A, et al. Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting (Review). Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.:CD002285. doi:10.1002/14651858.CD002285.pub2.
11. Grossi F., Tiseo M. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC). Critical Reviews in Oncology/Hematology 2006, 58(June (3)):221-230.
12. Jie Y., He W.G. Clinical observation on the treatment of non-small cell lung cancer using a combination of Chinese herbal medicine (no. 2) and chemotherapy (NP regimen). Cancer Research and Clinic 2006, 18(10):701-703.
13. Liu J.X., Niu H.M. Effects of YiqiYangyin Jiedu Fang on serum vascular endothelial growth factor and immunologic function in the patient of lung cancer. Journal of Traditional Chinese Medicine 2006, 47(3):190-192.
14. Sun H.X., Jiang S.Q., Pu B.K., et al. Randomized controlled trial investigating the effects of yi fei qing hua gel on postoperative early stage non-small cell lung cancer. Chinese Journal of Guang Ming Traditional Chinese Medicine 2005, 20(October (5)):55-58.
15. Liu F. Clinical observation to non-small cellular lung cancer treated with Fuzheng Guben decoction and chemotherapy. News report of the University of Zhejiang Traditional Chinese Medicine 2007, 31(3):316-318.
16. Huang X.W., Luo Q.D., Li Y.Q. Observation of the clinical effectiveness in treating late stage non-small cell lung cancer using JianPiHuaTan method combined with chemotherapy in 20 patients. New Journal of Traditional Chinese Medicine 2006, 38(9):53-55.
17. Yang C., Wang R.P. Clinical observation on using KeLiu pills to treat late stage non-small cell lung cancer. Chinese Archives of Traditional Chinese Medicine 2004, 22(11):2090-2091.
18. Xu Z.Y., Wang Z.Q., Zhu Y.W., et al. Influence of " Feiyanning Decoction" on Late non-small cell lung cancer metastasis and serum vascular endothelial growth factor. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiahque Shanghai 2003, 17(3):18-22.
19. Feng L., Hua B.J., Piao B.K. Clinical study of feiliuping II on quality of life of lung cancer patients. Chinese Journal of Information on Traditional Chinese Medicine 2006, 13(12):12-13.
20. Zhang W.Q., Du F.M., Zhao M.C., et al. Treatment of non-small cell lung cancer using Buqihuoxue method combined with chemotherapy. Zhejiang Journal of Integrated Chinese and Western Medicine 2005, 15(6):340-341.
21. Zhang A.Q., Sun Z.D., Bao S.Z. Clinical observation on the treatment of late stage lung cancer using Bazhen soup to reduce adverse side effects of chemotherapy in 36 cases. Fujian Journal of Traditional Chinese Medicine 2005, 36(3):18-19.
22. Yi L.H., Zhao F.D., Wang H.M. Clinical observation of treatment of late stage non-small cell lung cancer using Baiyin soup combined with chemotherapy. Acta Academic Medicine Jiangxi 2005, 45(1):96-97.
23. Li G., Zhang S.C., Yang L.J., et al. Clinical study on Qiankun capsule in treating lung cancer. Chinese Journal of Basic Medicine in Traditional Chinese Medicine 2004, 10(6):51-54.
24. Zhang S.C., Li G., Yang L.J. Clinical study on Qian kun capsule for the treatment of lung cancer. Journal of Traditional Chinese Medicine 2005, 46(1):32-35.
25. Ma L.Y. Investigation of treatment of primary bronchus derived lung cancer using Yifei capsules. Journal of Shandong University of Traditional Chinese Medicine 1998, 22(1):50-55.
26. Liu J.X., Xu Z.H., Xhi Z.M., et al. Prospective investigation on the treatment of 122 cases of late onset non-small cell lung cancer using Fuzhen method. Acta Medica Sinica 1987, 2(1):11-16.
27. Wang J.X., Zhu C.L., Gao Z.H., et al. A clinical observation of the effect of supplementing Qi and nourishing Yin prescription combined with MOP on the stage III IV of the non-small cell lung cancer. Journal of Practical Combination of TCM and Western Medicine 1997, 10(19):1839-1840.
28. Julka P.K., Doval D.C., Gupta S., et al. Response assessment in solid tumours: a comparison of WHO, SWOG and RECIST guidelines. The British Journal of Radiology 2008, 81:444-449.
29. Schag C.C., Heinrich R.L., Ganz P.A. Karnofsky performance status revisited: reliability, validity, and guidelines. Journal of Clinical Oncology 1984, 2:187-193.
30. Miller A.B, Hoogstraten B., Staquet M., et al. Reporting results of cancer treatment. Cancer 1981, 47:207-214.
31. Zhu P.Z. Chinese material medica: chemistry, pharmacology and applications 1998, Pb Harwood Academic Publishers.
32. Cho W.C., Leung K.N. In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus. Journal of Ethnopharmacology 2007, 113(1):132-141.
33. McCulloch M., See C., Shu X.J., et al. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. Journal of Clinical Oncology 2006, 24:3215-3216.
34. Hu Y.W., Liu C.Y., Du C.M., et al. Induction of apoptosis in human hepatocarcinoma SMMC-7721 cells in vitro by flavonoids from Astragalus complanatus. Journal of Ethnopharmacology 2009, 123(2):293-301.
35. Gao Q.T., Cheung J.K., Li J., et al. A Chinese herbal decoction, Danggui Buxue Tang, prepared from Radix Astragali and Radix Angelicae Sinensis stimulates the immune responses. Planta Medica 2006, 72(13):1227-1231.
36. Liu B., Peng H., Yao Q., et al. Bioinformatics analyses of the mannose-binding lectins from Polygonatum cyrtonema, Ophiopogon japonicus and Liparis noversa with antiproliferative and apoptosis-inducing activities. Phytomedicine 2009, 16(6-7):601-608.
37. Wu X., Dai H., Huang L., et al. A fructan, from Radix ophiopogonis, stimulates the proliferation of cultured lymphocytes: structural and functional analyses. Journal of National Product 2006, 69(9):1257-1260.
38. Lobo R, Prabhu K.S., Shirwaikar A., et al. Curcuma zedoaria Rosc. (white turmeric): a review of its chemical, pharmacological and ethnomedicinal properties. Journal of Pharmacy and Pharmacology 2009, 61:13-21.
39. 2+-mediated apoptosis in human breast cancer cells. Toxicology in Vitro 2009 August 15, [Epub ahead of print].
40. Shi Y., Wang C.H., Gong X.G. Apoptosis-inducing effects of two anthraquinones from Hedyotis diffusa WILLD. Biological and Pharmaceutical Bulletin 2008, 31(6):1075-1078.
41. Li G.Y., Yu X.M., Zhang H.W., et al. Haishengsu as an adjunct therapy to conventional chemotherapy in patients with non-small cell lung cancer: a pilot randomized and placebo-controlled clinical trial. Complementary Therapies in Medicine 2009, 17:51-55.
42. Nichols C.R., Fox E.P., Roth B.J., et al. Incidence of neutropenic fever in patients treated with standard-dose combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte colony-stimulating factor. Journal of Clinical Oncology 1994, 12(6):1245-1250.
43. Wright J.R., Yee C., Ung, et al. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small cell lung cancer with disease-related anemia. Journal of Clinical Oncology 2007, 9:1027-1032.
44. Granda-Cameron C., Viola S.R., Lynch M.P., et al. Measuring patient-oriented outcomes in palliative care: functionality and quality of life. Clinical Journal of Oncology Nursing 2008, 12(1):65-77.
45. Molassiotis A., Potrata B., Cheng K.K.F. A systematic review of the effectiveness of Chinese herbal medication in symptom management and improvement of quality of life in adult cancer patients. Complementary Therapies in Medicine 2008, 10.1016/j.ctim.2008.11.002.